Although we showed TJT could successfully improve the symptoms of obesity-AD comorbidity by regulating HIF-1α, the specific role of HIF-1α in the pathology of obesity-AD and the detailed regulatory mechanism of TJT require further investigation. The gene discussed is HIF1A; the disease is obesity due to melanocortin 4 receptor deficiency.